286 related articles for article (PubMed ID: 25886090)
1. Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study.
Guevara-Gutierrez E; Bonilla-Lopez S; Hernández-Arana S; Tlacuilo-Parra A
J Dermatolog Treat; 2015; 26(6):548-50. PubMed ID: 25886090
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
3. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Wan KS
J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
[TBL] [Abstract][Full Text] [Related]
5. Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
Barniol C; Dehours E; Mallet J; Houze-Cerfon CH; Lauque D; Charpentier S
Ann Emerg Med; 2018 Jan; 71(1):125-131.e1. PubMed ID: 28476259
[TBL] [Abstract][Full Text] [Related]
6. Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life.
Okubo Y; Shigoka Y; Yamazaki M; Tsuboi R
J Dermatolog Treat; 2013 Apr; 24(2):153-60. PubMed ID: 21810005
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria.
Zhong J; Xian D; Xu Y; Liu J
J Altern Complement Med; 2011 May; 17(5):459-64. PubMed ID: 21568746
[TBL] [Abstract][Full Text] [Related]
8. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal.
Dhanya NB; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(5):475-7. PubMed ID: 19052407
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
10. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.
Bagenstose SE; Levin L; Bernstein JA
J Allergy Clin Immunol; 2004 Jan; 113(1):134-40. PubMed ID: 14713918
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial.
Gastaminza G; Azofra J; Nunez-Cordoba JM; Baeza ML; Echechipía S; Gaig P; García BE; Labrador-Horrillo M; Sala-Cunill A; Brescó MS; Beristain A; Quiñones D; Donado CD; Zubeldia JM; Ferrer M
J Allergy Clin Immunol Pract; 2019; 7(5):1599-1609.e1. PubMed ID: 30654196
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
13. Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety.
Sil A; Tripathi SK; Chaudhuri A; Das NK; Hazra A; Bagchi C; Islam CN
J Dermatolog Treat; 2013 Dec; 24(6):466-72. PubMed ID: 23163959
[TBL] [Abstract][Full Text] [Related]
14. Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar
Marrouche N; Williams HC
Indian J Dermatol Venereol Leprol; 2018; 84(1):59-60. PubMed ID: 29271368
[No Abstract] [Full Text] [Related]
15. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.
Pacor ML; Di Lorenzo G; Corrocher R
Clin Exp Allergy; 2001 Oct; 31(10):1607-14. PubMed ID: 11678862
[TBL] [Abstract][Full Text] [Related]
18. Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study.
Kalogeromitros D; Kempuraj D; Katsarou-Katsari A; Makris M; Gregoriou S; Papaliodis D; Theoharides TC
Int Arch Allergy Immunol; 2006; 139(3):258-64. PubMed ID: 16449816
[TBL] [Abstract][Full Text] [Related]
19. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
20. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
Sharma VK; Gupta V; Pathak M; Ramam M
J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
